SS

Swapnil Swami

Active Director Director DIN 07263697
DIN 07263697 First appointment Oct 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Swapnil Swami

Data last updated:

Swapnil Swami is a Director at Zenrax Healthcare India Private Limited (since 2015). The company operates in Chemicals. Zenrax Healthcare India Private Limited reported revenue of ₹4.5 Lakh (FY 2021).

DIN 07263697
Primary Designation Director
Industry Chemicals
First Appointment 15 Oct 2015
Oldest Company Age 11 yrs
Largest company Zenrax Healthcare India Private Limited · ₹4.5 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Oct 20152015₹4.5 Lakh (FY 2021)Active

Board colleagues of Swapnil Swami

Directorship timeline

Open interactive timeline →
Zenrax Healthcare India Private Limited
Premium access

Shareholding and investment profile for Swapnil Swami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swapnil Swami

Swapnil Swami currently holds 1 directorship: Zenrax Healthcare India Private Limited (Director, since 15 Oct 2015, revenue ₹4.5 Lakh (FY 2021)).

Swapnil Swami was first appointed on 15 Oct 2015 as Director at Zenrax Healthcare India Private Limited.

The current boards of Swapnil Swami's companies include Manish Upadhyay (Zenrax Healthcare India Private Limited), Vinay Swami (Zenrax Healthcare India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available